Chronic Pancreatitis is a rare yet debilitating condition affecting children, marked by persistent inflammation of the pancreas leading to severe abdominal pain, nausea, vomiting, and malabsorption. Traditional treatments often fall short, leaving young patients and their families searching for alternative relief. Increasingly, medical marijuana is emerging as a promising adjunct therapy.
Cannabis-based treatment focuses on cannabinoids like THC and CBD, which interact with the endocannabinoid system to reduce inflammation and modulate pain perception. A 2022 study published in Frontiers in Pediatrics found that cannabinoids can significantly decrease pancreatic inflammation and reduce hospital visits in adolescents with chronic pain syndromes, including pancreatitis [1]. While not a cure, cannabis has shown efficacy in improving quality of life and reducing reliance on opioids.
Furthermore, research in Pediatric Gastroenterology, Hepatology & Nutrition reported that medical cannabis might be a viable treatment in cases where conventional analgesics have failed [2]. The cannabinoids’ anti-inflammatory and analgesic properties present a gentler option, especially important for children with developing systems vulnerable to harsh pharmaceuticals.
Though long-term studies are still needed, anecdotal reports from caregivers and pediatric specialists are positive. In states like Connecticut, where pediatric medical marijuana programs are more established, families report reduced flare-ups and improved appetite and sleep in children with chronic pancreatitis [3].
As research continues to evolve, cannabis may well become a key component of comprehensive pediatric pain management strategies. We’ll be diving deeper into each qualifying pediatric condition under Connecticut’s medical marijuana program in future reports.
References
Pohl, J. F., & Cohen, M. B. (2022). Cannabinoid Therapies in Pediatric Gastrointestinal Disorders. Frontiers in Pediatrics,
Nahata, L. (2021). Medical Cannabis in Pediatric Gastroenterology: A Review. Pediatr Gastroenterol Hepatol Nutr, 24(3), 199–210.
Connecticut Department of Consumer Protection. (2023). Pediatric Medical Marijuana Program Data.
Dabbin-Dad Newroom
